Subscribe:

Financial Assistance From Susan G. Komen®

September 10, 2019

Susan G. Komen® is committed to bridging financial gaps for underserved individuals coping with breast cancer across the country. Offered in partnership with CancerCare, the Susan G. Komen Treatment Assistance Program is open to low-income, underinsured or uninsured women who are actively undergoing treatment for breast cancer.

Read more »

CancerCare and Savor Health® Announce Partnership and Introduce Ina™, the Intelligent Nutrition Assistant

July 29, 2019
Display photo for CancerCare and Savor Health® Announce Partnership and Introduce Ina™, the Intelligent Nutrition Assistant

In partnership with Savor Health®, we are happy to introduce Ina™, the Intelligent Nutrition Assistant.

Read more »

CancerCare Receives Funding for Low-Income New Yorkers Facing a Cancer Diagnosis

March 26, 2019
Display photo for CancerCare Receives Funding for Low-Income New Yorkers Facing a Cancer Diagnosis

CancerCare recently received a $700,000 grant from The New York Community Trust to provide financial assistance to low-income New Yorkers affected by cancer.

Read more »

CancerCare’s Vilmarie Rodriguez, Director of Patient Assistance Programs, Receives Emerald Leader Award of the National Association of Social Workers

March 22, 2019
Display photo for CancerCare’s Vilmarie Rodriguez, Director of Patient Assistance Programs, Receives Emerald Leader Award of the National Association of Social Workers

CancerCare is thrilled to announce Vilmarie Rodriguez, Director of Patient Assistance Programs, LCSW, is the recipient of the Emerald Leader Award of the National Association of Social Workers – New York City Chapter (NASW-NYC).

Read more »

CancerCare Hosts Sephora Brave Beauty Class for Confidence to Support Women Living With Cancer

February 27, 2019
Display photo for Cancer*Care* Hosts Sephora Brave Beauty Class for Confidence to Support Women Living With Cancer

“The Sephora Brave Beauty classes are special for so many reasons,” said Maryrose Mongelli, LMSW CancerCare’s Women’s Cancers Program Coordinator. “It’s all about making these women feel good and confident about themselves, throughout their difficult journey.”

Read more »

Winter Wonderland Holiday Party 2018

December 18, 2018
Display photo for Winter Wonderland Holiday Party 2018

For the third year, CancerCare, in partnership with Flatiron Health, hosted a fun-filled Winter Wonderland Holiday Party. The party was open to all of CancerCare’s clients, including families, adults and caregivers affected by cancer. Flatiron Health graciously hosted 120+ children, adults and staff members in their office space in the Soho neighborhood of New York City.

Read more »

CancerCare Announces Findings From Second Lung Cancer Roundtable

November 5, 2018
Display photo for CancerCare Announces Findings From Second Lung Cancer Roundtable

CancerCare recently held a second lung cancer roundtable discussion titled, “The Role of Lung Advocacy Organizations in Biomarker Testing.”

Read more »

Sephora Makeup Artists Bring Positivity and Fun to CancerCare Event

June 6, 2018
Display photo for Sephora Makeup Artists Bring Positivity and Fun to CancerCare Event

On Wednesday, May 2, four makeup artists from Sephora’s Herald Square store visited CancerCare’s National Office to offer complementary consultations to people with cancer and their loved ones.

Read more »

CancerCare and LUNGevity Financial Toxicity Survey

April 24, 2018
Display photo for CancerCare and LUNGevity Financial Toxicity Survey

CancerCare, in partnership with LUNGevity Foundation, is interested in understanding the burden of financial toxicity associated with lung cancer diagnosis and treatment.

Read more »

March 3 is Triple Negative Breast Cancer Day

March 2, 2018
Display photo for March 3 is Triple Negative Breast Cancer Day

Triple negative breast cancer (TNBC) is a breast cancer subtype, which is found in 10-20% of all breast cancer diagnoses each year. The name originates from tumors found in the breast that are estrogen receptor-negative, progesterone receptor-negative, and human epidermal growth factor receptor 2-negative. In other words, TNBC tumors do not exhibit any of these three receptors. Although these tumors do not respond to receptor-specific treatments, they are typically responsive to chemotherapy.

Read more »
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.